These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5941785)

  • 21. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 22. [Protection of PNH red blood cells from lysis by transferring GPI-anchored protein vesicles of normal human RBCs in vitro].
    Yang Y; Xu C; Pan H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):278-81. PubMed ID: 12567450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.
    Ferreira VP; Pangburn MK
    Blood; 2007 Sep; 110(6):2190-2. PubMed ID: 17554058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
    Nakakuma H
    Am J Hematol; 1996 Sep; 53(1):22-9. PubMed ID: 8813092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hiken J
    Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
    Risitano AM
    Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH.
    Ninomiya H; Kawashima Y; Hasegawa Y; Nagasawa T
    Br J Haematol; 1999 Jul; 106(1):224-31. PubMed ID: 10444191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.
    Luzzatto L; Gianfaldoni G
    Int J Hematol; 2006 Aug; 84(2):104-12. PubMed ID: 16926130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perisurgical induction of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria: its inhibition of surgery-triggered hemolysis and the consequence of subsequent discontinuation.
    Kurita N; Obara N; Fukuda K; Nishikii H; Sato S; Inagawa S; Kurokawa T; Owada Y; Ninomiya H; Chiba S
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):658-62. PubMed ID: 23917586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halting targeted and collateral damage to red blood cells by the complement system.
    Jalink M; de Boer ECW; Evers D; Havinga MQ; Vos JMI; Zeerleder S; de Haas M; Jongerius I
    Semin Immunopathol; 2021 Dec; 43(6):799-816. PubMed ID: 34191092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria.
    Rotoli B; Robledo R; Scarpato N; Luzzatto L
    Blood; 1984 Oct; 64(4):847-51. PubMed ID: 6478058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.
    NISHIOKA K; LINSCOTT WD
    J Exp Med; 1963 Nov; 118(5):767-93. PubMed ID: 14087621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells.
    Sica M; Notaro R
    Am J Hematol; 2024 Mar; 99(3):505-507. PubMed ID: 38264841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on immune human hemolysis. I. The kinetics of the Donath-Land-steiner reaction and the requirement for complement in the reaction.
    HINZ CF; PICKEN ME; LEPOW IH
    J Exp Med; 1961 Jan; 113(1):177-218. PubMed ID: 13714487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red Blood Cell Homeostasis and Altered Vesicle Formation in Patients With Paroxysmal Nocturnal Hemoglobinuria.
    Freitas Leal JK; Preijers F; Brock R; Adjobo-Hermans M; Bosman G
    Front Physiol; 2019; 10():578. PubMed ID: 31156458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes.
    GREEN H; BARROW P; GOLDBERG B
    J Exp Med; 1959 Nov; 110(5):699-713. PubMed ID: 13851485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement.
    Muzykantov VR; Smirnov MD; Klibanov AL
    FEBS Lett; 1993 Mar; 318(2):108-12. PubMed ID: 8440366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the
    Yatime L; Merle NS; Hansen AG; Friis NA; Østergaard JA; Bjerre M; Roumenina LT; Thiel S; Kristensen P; Andersen GR
    Front Immunol; 2018; 9():2822. PubMed ID: 30555486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond.
    Peffault de Latour R; Risitano AM
    Am J Hematol; 2023 May; 98 Suppl 4():S3-S4. PubMed ID: 36917199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.